{
  "name": "Clonazepam",
  "genericName": "clonazepam",
  "brandNames": ["Klonopin", "Rivotril"],
  "tags": ["Benzodiazepine", "Anxiolytic", "Anticonvulsant"],
  "dosing": {
    "adult_acute": "Panic disorder: 0.25 mg BID; Seizures: 0.5 mg TID",
    "adult_maintenance": "Panic: 1-4 mg/day divided BID; Seizures: 0.5-20 mg/day divided",
    "notes": "Long-acting benzodiazepine; FDA-approved for panic disorder; ODT formulation available; higher potency",
    "canadian_clinical": {
      "starting_dose": "0.25-0.5 mg BID",
      "titration_schedule": "Increase by 0.25-0.5 mg every 3 days",
      "max_dose_evidence": "4 mg/day (panic); 20 mg/day (seizures)",
      "max_dose_practice": "2-4 mg/day for panic; avoid chronic use",
      "inpatient_strategy": "Start 0.5-1 mg BID-TID; higher doses for akathisia or agitation",
      "outpatient_strategy": "Start 0.25-0.5 mg BID; titrate slowly; time-limited use; taper plan from onset"
    }
  },
  "warnings": [
    "Black box warning: (1) Concomitant use with opioids may result in respiratory depression, coma, death; (2) Abuse, misuse, addiction; (3) Dependence and withdrawal",
    "Long half-life (30-40 hours) - accumulation risk",
    "Physical dependence with regular use - difficult withdrawal",
    "Withdrawal seizures possible - MUST taper slowly (10% dose reduction every 1-2 weeks)",
    "Cognitive impairment, memory issues, sedation",
    "HIGH abuse potential - Schedule IV controlled substance",
    "Should be SHORT-TERM use only; avoid long-term except seizure disorders"
  ],
  "cautions": {
    "renal": "Use with caution; metabolites may accumulate",
    "hepatic": "Reduce dose in hepatic impairment; increased sensitivity",
    "pregnancy": "Pregnancy Category D - avoid; teratogenic risk"
  },
  "citations": ["Klonopin FDA Label", "APA Panic Disorder Guidelines", "Ashton Manual (Benzodiazepine Withdrawal)"]
}
